Predictors of breakthrough clinically significant cytomegalovirus infection during letermovir prophylaxis in high‐risk hematopoietic cell transplant recipients

Letermovir prophylaxis in allogeneic hematopoietic cell transplant recipients significantly reduces the incidence of clinically significant cytomegalovirus infection. However, breakthrough infections still occur despite adequate prophylaxis. In the present retrospective cohort study, we identified c...

Descripción completa

Detalles Bibliográficos
Autores principales: Royston, Léna, Royston, Eva, Masouridi‐Levrat, Stavroula, Chalandon, Yves, Van Delden, Christian, Neofytos, Dionysios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342239/
https://www.ncbi.nlm.nih.gov/pubmed/33949798
http://dx.doi.org/10.1002/iid3.431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342239/
https://www.ncbi.nlm.nih.gov/pubmed/33949798
http://dx.doi.org/10.1002/iid3.431

Ejemplares similares